Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
D000107:Acetylation; D001241:Aspirin / Q000494:pharmacology* / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D001808:Blood Vessels / Q000166:cytology / Q000187:drug effects; D002986:Clinical Trials as Topic; D004176:Dipyridamole / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D013442:Sulfinpyrazone / Q000494:pharmacology* / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
D004176:Dipyridamole; D013930:Thromboxane-A Synthase; D001241:Aspirin; D013442:Sulfinpyrazone